Amyotrophic Lateral Sclerosis Therapy Development Institute
The ALS Therapy Development Institute is a non-profit biotechnology research organization focused on finding treatments for amyotrophic lateral sclerosis. With a staff including more than 30 scientists, it operates a research and development program centered on ALS. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Amyotrophic Lateral Sclerosis Therapy Development Institute, United States, covering academic research published from 2001 to 2024. Read More.
Open Access Percentage
75%
Total
Publications
52
Total Open
Publications
39
Total
Citations
4.7K
Open Access
Percentage
75%
Total
Publications
52
Total Open
Publications
39
Total
Citations
4.7K
Breakdown
Publisher Open
18%
Both
40%
Other Platform Open
16%
Closed
26%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 59%
17
Hybrid 7%
2
No Guarantees 34%
10
Other Platform Open
Domain 73%
22
Other Internet 23%
7
Preprint 17%
5
Public 17%
5
Institution 7%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 22 |
DOI | Other Internet | 7 |
Figshare | Public | 5 |
medRxiv | Preprint | 2 |
Europe PMC | Domain | 2 |
bioRxiv | Preprint | 2 |
Virginia Tech | Institution | 1 |
Harvard University | Institution | 1 |
arXiv | Preprint | 1 |